Market Research Logo

United States Cardiac Assist Devices Market Outlook to 2025

United States Cardiac Assist Devices Market Outlook to 2025

Summary

GlobalData’s new report, United States Cardiac Assist Devices Market Outlook to 2025, provides key market data on the United States Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Cardiac Assist Devices market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Cardiac Assist Devices market.
  • Global corporate-level profiles of key companies operating within the United States Cardiac Assist Devices market.
  • Key players covered include Abbott Laboratories, Medtronic plc, Getinge AB. and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiac assist devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiac Assist Devices Market, United States
3.1 Cardiac Assist Devices Market, United States, Revenue ($m), 2015-2025
3.1.1 Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Ventricular Assist Devices Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Cardiac Assist Devices Market, United States, Volume (Units), 2015-2025
3.2.1 Intra-Aortic Balloon Pumps Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Ventricular Assist Devices Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Cardiac Assist Devices Market, United States, Average Price ($), 2015-2025
3.4 Cardiac Assist Devices Market, United States, Distribution Share by Revenue ($m), 2017
3.5 Cardiac Assist Devices Market, United States, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in United States, Cardiac Assist Devices Market
4.1 Abbott Laboratories
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 Getinge AB
4.3.1 Company Overview
4.4 Teleflex Inc
4.4.1 Company Overview
4.5 Syncardia Systems LLC
4.5.1 Company Overview
5 Cardiac Assist Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Private Equity
6.1.1 Audax Private Equity Acquires Belmont Instrument
6.2 Venture Financing
6.2.1 Ariste Medical Raises USD0.3 Million in Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jan 10, 2018: Ventripoint Appoints Head of Sales for North America
7.1.2 Dec 19, 2017: Ventripoint Diagnostics Provides Corporate Update
7.1.3 Dec 08, 2017: Micron Solutions Designates Mr. E. P. Marinos as a Director Emeritus and Appoints Mr. Andrei Soran to its Board of Directors
7.1.4 Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant
7.1.5 Jul 24, 2017: Micron Solutions Appoints Rodd E. Friedman to its Board of Directors
7.1.6 Jul 20, 2017: A Third Highly Successful Ultrasound Executive joins Ventripoint
7.1.7 Jun 21, 2017: Highly Successful Global Industry Sales & Marketing Executives Hired by Ventripoint
7.2 Financial Announcements
7.2.1 Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year
7.2.2 Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year
7.2.3 Nov 13, 2017: Micron Solutions Reports 2017 Third Quarter Results
7.2.4 Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33%
7.2.5 Oct 23, 2017: REVA to Present Fantom 24-Month Data at TCT 2017
7.2.6 Oct 16, 2017: Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer at Upcoming AACR-NCI-EORTC International Conference
7.2.7 Sep 09, 2017: Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine
7.2.8 Aug 11, 2017: Micron Solutions Reports 2017 Second Quarter Results
7.2.9 Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year
7.2.10 May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year
7.3 Product News
7.3.1 Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations
7.3.2 Nov 27, 2017: Ventripoint Invents a New Way to Track Ultrasound Probes That Will Speed up Exams
7.3.3 Oct 19, 2017: Abiomed's Impella Technology that Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations
7.3.4 Jun 09, 2017: Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology
7.3.5 Jun 01, 2017: Medical Device Company TandemLife Set to Simplify Life Support
7.4 Strategy And Business Planning
7.4.1 Nov 20, 2017: DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients
7.4.2 Mar 30, 2017: Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Cardiac Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Cardiac Assist Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Ventricular Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Ventricular Assist Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Cardiac Assist Devices Market, United States, Volume (Units), 2015-2020
Table 8: Cardiac Assist Devices Market, United States, Volume (Units), 2021-2025
Table 9: Intra-Aortic Balloon Pumps Market, United States, Volume (Units), 2015-2020
Table 10: Intra-Aortic Balloon Pumps Market, United States, Volume (Units), 2021-2025
Table 11: Ventricular Assist Devices Market, United States, Volume (Units), 2015-2020
Table 12: Ventricular Assist Devices Market, United States, Volume (Units), 2021-2025
Table 13: Cardiac Assist Devices Market, United States, Average Price ($), 2015-2020
Table 14: Cardiac Assist Devices Market, United States, Average Price ($), 2021-2025
Table 15: Cardiac Assist Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 16: Cardiac Assist Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 17: Cardiac Assist Devices Market Pipeline Products
Table 18: Audax Private Equity Acquires Belmont Instrument
Table 19: Ariste Medical Raises USD0.3 Million in Financing
Table 20: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country
1.2 List of Figures
Figure 1: Cardiac Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Ventricular Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Cardiac Assist Devices Market, United States, Volume (Units), 2015-2025
Figure 5: Intra-Aortic Balloon Pumps Market, United States, Volume (Units), 2015-2025
Figure 6: Ventricular Assist Devices Market, United States, Volume (Units), 2015-2025
Figure 7: Cardiac Assist Devices Market, United States, Company Share (%) 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report